Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

XENE

19 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in Xenon Pharmaceuticals Inc.

Yes. Polar Capital Holdings holds 4,570,556 shares of XENE (Xenon Pharmaceuticals), worth $275.9M, as of its Q2 2026 13F filing. It increased the position by 165,244 shares (+3.8%) from Q1 2026. Polar Capital Holdings has held XENE since Q4 2021, across 19 quarterly 13F filings. XENE is 0.7% of Polar Capital Holdings' reported 13F portfolio.

Current Value

$275.9M

Current Shares

4.6M

Total Value Change

+$223.1M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.6M
+3.8%
$275.9M0.7%$60.36
45
2026-Q1
Increased
4.4M
+78.7%
$256.2M0.9%$43.79
66
2025-Q4
Decreased
2.5M
-3.2%
$110.5M0.4%$44.12
0
2025-Q3
Decreased
2.5M
-5.8%
$102.3M0.5%$39.06
0
2025-Q2
Increased
2.7M
+3.1%
$84.6M0.4%$32.40
37
2025-Q1
Decreased
2.6M
-2.8%
$88M0.5%$34.26
0
2024-Q4
Increased
2.7M
+10.3%
$105.7M0.6%$38.53
47
2024-Q3
Decreased
2.4M
-3.6%
$96.2M0.5%$38.65
0
2024-Q2
Decreased
2.5M
-2.9%
$98.9M0.6%$38.99
0
2024-Q1
Decreased
2.6M
-14.8%
$112.5M0.6%$43.05
0
2023-Q4
Increased
3.1M
+2.1%
$141.2M0.9%$46.06
43
2023-Q3
Decreased
3M
-0.6%
$102.6M0.8%$34.16
0
2023-Q2
Increased
3M
+0.2%
$116.3M0.6%$38.43
42
2023-Q1
Decreased
3M
-0.9%
$108M0.7%$35.61
0
2022-Q4
Increased
3M
+14.4%
$120.1M1.0%$39.43
48
2022-Q3
Increased
2.7M
+4.8%
$96.1M0.6%$35.89
44
2022-Q2
Increased
2.5M
+16.0%
$77.3M0.5%$30.90
41
2022-Q1
Increased
2.2M
+29.7%
$67M0.3%$30.12
45
2021-Q4
New
1.7M
-
$52.7M0.2%$31.99
49

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used